Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabarcoding Reveals the Dietary Patterns of Bats Within a Unique European Habitat, the Pasture-Dominated Landscapes of Ireland.

Ecology and evolution·2025
Same author

Oncotype DX Breast DCIS Score® Test: Impact on Radiotherapy Recommendations and Patient Decisional Anxiety.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Effect of drain omission after mastectomy on cosmesis, patient satisfaction and interval to adjuvant therapy.

Annals of the Royal College of Surgeons of England·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

[Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].

Revue des maladies respiratoires·2024
Same author

[Medico-economic evaluation of the PRADO-BPCO post-exacerbation support program].

Revue des maladies respiratoires·2024

Related Experiment Video

Updated: Jun 17, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.

P-R Burgel1, J-L Paillasseur, D Caillaud

  • 1Service de Pneumologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, 27 rue du Faubourg St Jacques, 75679 Paris Cedex 14, France. pierre-regis.burgel@cch.aphp.fr

The European Respiratory Journal
|January 16, 2010
PubMed
Summary

Chronic obstructive pulmonary disease (COPD) classification needs improvement. New multidimensional COPD phenotypes were identified using cluster analysis, revealing patient heterogeneity beyond airflow limitation for better care.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Jun 17, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

  • Pulmonary Medicine
  • Clinical Research
  • Data Science in Healthcare

Background:

  • Current chronic obstructive pulmonary disease (COPD) classification relies on airflow limitation severity.
  • This traditional method may not capture the full phenotypic heterogeneity of COPD patients.
  • Identifying distinct COPD phenotypes is crucial for personalized treatment and clinical trial design.

Purpose of the Study:

  • To identify COPD phenotypes using a multidimensional approach incorporating various clinical variables.
  • To evaluate if these identified phenotypes offer a more nuanced classification than the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging.
  • To assess the clinical implications of these phenotypes regarding patient characteristics and outcomes.

Main Methods:

  • Principal Component Analysis (PCA) was used to analyze eight key COPD-related variables from 322 subjects.
  • Cluster analysis was performed on PCA-transformed data to classify patients into distinct phenotypes.
  • Variables included age, smoking history, FEV(1), BMI, exacerbations, dyspnea, health status, and depressive symptoms.

Main Results:

  • PCA identified three independent components explaining 61% of the variance in COPD characteristics.
  • Cluster analysis revealed four distinct COPD phenotypes, not discernible by GOLD classification alone.
  • Patients with similar airflow limitation (FEV(1)) were assigned to different phenotypes, exhibiting variations in age, symptoms, comorbidities, and mortality risk.

Conclusions:

  • The study highlights significant phenotypic heterogeneity in COPD that is not captured by current airflow-based classification.
  • A multidimensional approach is necessary for a more accurate COPD classification.
  • These novel phenotypes could enhance patient care strategies and improve the design and interpretation of clinical trials for COPD.